125 related articles for article (PubMed ID: 12733146)
1. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.
Uemura M; Nouso K; Kobayashi Y; Tanaka H; Nakamura S; Higashi T; Ono T; Nakayama E; Hanafusa T; Shiratori Y
Cancer; 2003 May; 97(10):2474-9. PubMed ID: 12733146
[TBL] [Abstract][Full Text] [Related]
2. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies.
Chen X; Fu S; Chen F; Chen H; Chen Z
Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843
[TBL] [Abstract][Full Text] [Related]
4. Definition of tumor-associated antigens in hepatocellular carcinoma.
Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):285-90. PubMed ID: 10750667
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.
Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J
Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375
[TBL] [Abstract][Full Text] [Related]
6. [Screening and analysis of genes encoding hepatocellular carcinoma associated tumor antigens].
Wang HC; Yang MH; Shi YY; Pang XW; Yang XA; Peng JR; Leng XS; Chen WF
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):343-6. PubMed ID: 15918967
[TBL] [Abstract][Full Text] [Related]
7. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
8. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
[TBL] [Abstract][Full Text] [Related]
9. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
10. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
11. Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinoma.
Wang HC; Su YR; Han KJ; Pang XW; Peng JR; Liang B; Wang S; Chen WF
Biochem Cell Biol; 2004 Apr; 82(2):321-7. PubMed ID: 15060627
[TBL] [Abstract][Full Text] [Related]
12. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y
J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
[TBL] [Abstract][Full Text] [Related]
13. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma.
Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Harada T; Fujimoto M; Sakaida I; Okita K; Oka M; Nakamura K
Proteomics; 2006 Jul; 6(13):3894-900. PubMed ID: 16767786
[TBL] [Abstract][Full Text] [Related]
15. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
18. [Screening and identification of human nasopharyngeal carcinoma-associated antigens].
Cui XB; Xie K; LiangG CY; Deng HX; Wei YQ; Tian L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):800-3. PubMed ID: 16334557
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
20. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
